Clinical Trial Update: GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC) [NA]

View source ↗

Summary

This clinical trial update reports a completed study of GV-1001 immunotherapy in patients with Non-Small Cell Lung Cancer. The document provides limited detail …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• GV-1001

Snippet

Sponsor: Oslo University Hospital | Conditions: Carcinoma, Non-Small-Cell Lung | NA | Status: COMPLETED